Search

Search Constraints

You searched for: Author/Creator Le, Robert Q.

Search Results

1. FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome. (6th April 2018)